Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. HEXO.CA updated stock price target summary. Cormark reduced its target price from $4.15 to $2.45. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 1.05% and 0.52%, respectively, in early deals. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Want to see which stocks are moving? The high price target for HEXO is $4.00 and the low price target for HEXO is $0.75. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. The lighter blue line represents the stock's consensus price target. Also, the company reported net revenues of $15.4 million for the fourth quarter. When is Zogenix, Inc. (ZGNX) going to be good investment? This is mostly due to a rise in operating costs related to expansions. Get short term trading ideas from the MarketBeat Idea Engine. The analysts covering the stock grew from 8 last month to 14 this month. Innovative Industrial Properties, Inc. (IIPR) is the first company to focus on investing in real estate for medical marijuana companies. In recent trading session, HEXO Corp. (NYSE:HEXO) saw 2,929,552 shares changing hands with its beta currently measuring 0. Get daily stock ideas top-performing Wall Street analysts. Learn more. In recent news, HEXO’s unlicensed inventory is scheduled for destruction. Long term indicators on average place the stock in the category of 50% Sell. Export data to Excel for your own analysis. Currently, 14 analysts cover HEXO stock. The chart below shows how a company's share price and consensus price target have changed over time. Start Your Risk-Free Trial Subscription Here, Pfizer (NYSE:PFE) Stock: A Strong Option for Dividend Investors. HEXO Corp: Analysts’ Ratings and Price Target, FSD Pharma Reported Q3 Earnings after Losses, US Government Prohibits Funding for Marijuana, How MedMen Is Staking Its Claim in Cannabis Retail, New Jersey Could Loosen Its Marijuana Laws in 2020, Innovative Industrial Properties Company Overview, A Closer Look at Arizona’s Marijuana Laws, Tilray Exports to Switzerland and 13 Other Countries, Scotts Miracle-Gro: Analysts’ Ratings after Q4, KushCo: 6 Analysts Say “Buy,” Price Target Shrinks, Candidates Condemn Biden’s Gateway Drug Views, Charlotte’s Web: An Overview of a Cannabis Giant, Here’s What Delta 9 Cannabis 2.0 Looks Like, Know the Pros and Cons of Cannabis Edibles. View our full suite of financial calendars and market data tables, all for free. Shares short dropped in August from the previous month at 32.47 Million. The company has a 12-month trailing PE ratio of 0. Why Buy stock in Capricor Therapeutics, Inc. (CAPR)? MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.